| scholarly article | Q13442814 |
| P2093 | author name string | Stephen S G Ferguson | |
| Cornelia Walther | |||
| P2860 | cites work | Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes | Q22008730 |
| Functional Selectivity and Classical Concepts of Quantitative Pharmacology | Q22242288 | ||
| beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2 | Q22253360 | ||
| beta 1-adrenergic receptor association with the synaptic scaffolding protein membrane-associated guanylate kinase inverted-2 (MAGI-2). Differential regulation of receptor internalization by MAGI-2 and PSD-95 | Q24291617 | ||
| Human follitropin receptor (FSHR) interacts with the adapter protein 14-3-3tau | Q24296814 | ||
| SNX27 mediates PDZ-directed sorting from endosomes to the plasma membrane | Q24297153 | ||
| Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteins | Q24297397 | ||
| SNX27 mediates retromer tubule entry and endosome-to-plasma membrane trafficking of signalling receptors | Q24304190 | ||
| Beta-2 adrenergic receptor mediated ERK activation is regulated by interaction with MAGI-3 | Q24305154 | ||
| Mammalian Alpha Arrestins Link Activated Seven Transmembrane Receptors to Nedd4 Family E3 Ubiquitin Ligases and Interact with Beta Arrestins | Q24305954 | ||
| The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange | Q24310009 | ||
| Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation | Q24314684 | ||
| 14-3-3 dimers probe the assembly status of multimeric membrane proteins | Q44406301 | ||
| Shear stress-induced Ang II AT1 receptor activation: G-protein dependent and independent mechanisms | Q44712803 | ||
| NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer | Q45092731 | ||
| The PDZ protein mupp1 promotes Gi coupling and signaling of the Mt1 melatonin receptor | Q46672501 | ||
| The PDZ/coiled-coil domain containing protein PIST modulates insulin secretion in MIN6 insulinoma cells by interacting with somatostatin receptor subtype 5. | Q46785901 | ||
| G protein-coupled receptors. II. Mechanism of agonist activation | Q47860164 | ||
| Convergent pathways link the endothelin A receptor to the beta-catenin: the beta-arrestin connection | Q47937386 | ||
| PDZK1/NHERF3 differentially regulates corticotropin-releasing factor receptor 1 and serotonin 2A receptor signaling and endocytosis | Q48139659 | ||
| Role of SAP97 in the regulation of 5-HT2AR endocytosis and signaling | Q48681353 | ||
| The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation | Q50335944 | ||
| Interaction of the human prostacyclin receptor and the NHERF4 family member intestinal and kidney enriched PDZ protein (IKEPP). | Q54491545 | ||
| Intracellular dynamics of sst5 receptors in transfected COS-7 cells: maintenance of cell surface receptors during ligand-induced endocytosis | Q57042548 | ||
| Jak2 Acts as Both a STAT1 Kinase and as a Molecular Bridge Linking STAT1 to the Angiotensin II AT1Receptor | Q57630557 | ||
| Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2 | Q58450964 | ||
| Mechanism of rhodopsin kinase activation | Q70231775 | ||
| The Type I Angiotensin II Receptor Couples to Stat1 and Stat3 Activation Through Jak2 Kinase in Neonatal Rat Cardiac Myocytes | Q73702843 | ||
| Biphasic Activation of the JAK/STAT Pathway by Angiotensin II in Rat Cardiomyocytes | Q74191249 | ||
| Angiotensin II Activates Stat5 Through Jak2 Kinase in Cardiac Myocytes | Q74591579 | ||
| 14-3-3 proteins: regulation of endoplasmic reticulum localization and surface expression of membrane proteins | Q83976173 | ||
| Arrestin2 modulates androgen receptor activation | Q87537652 | ||
| Α-arrestins - new players in Notch and GPCR signaling pathways in mammals | Q87572745 | ||
| The human thyrotropin receptor: a heptahelical receptor capable of stimulating members of all four G protein families | Q24315862 | ||
| A novel association of mGluR1a with the PDZ scaffold protein CAL modulates receptor activity | Q24316667 | ||
| A C-terminal motif found in the β 2 -adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na + /H + exchanger regulatory factor family of PDZ proteins | Q24316901 | ||
| Interaction of the human somatostatin receptor 3 with the multiple PDZ domain protein MUPP1 enables somatostatin to control permeability of epithelial tight junctions | Q24324185 | ||
| 14-3-3 isotypes facilitate coupling of protein kinase C-zeta to Raf-1: negative regulation by 14-3-3 phosphorylation | Q24531905 | ||
| NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activation | Q24563311 | ||
| Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds | Q24605173 | ||
| Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7 | Q24651175 | ||
| The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis | Q24651529 | ||
| The structural basis of arrestin-mediated regulation of G-protein-coupled receptors | Q24657537 | ||
| MAGI-3 regulates LPA-induced activation of Erk and RhoA | Q24680474 | ||
| Catabolic and anabolic actions of parathyroid hormone on the skeleton | Q26828873 | ||
| Elucidation of the binding preferences of peptide recognition modules: SH3 and PDZ domains | Q27006986 | ||
| Role of PDZ Proteins in Regulating Trafficking, Signaling, and Function of GPCRs: Means, Motif, and Opportunity | Q27015870 | ||
| Persistent cAMP-signals triggered by internalized G-protein-coupled receptors | Q27329609 | ||
| The 2.0 A crystal structure of a heterotrimeric G protein | Q27732250 | ||
| Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11. | Q27865310 | ||
| PDZ Protein Regulation of G Protein-Coupled Receptor Trafficking and Signaling Pathways | Q28082062 | ||
| Distinct roles for β‐arrestin2 and arrestin‐domain‐containing proteins in β2 adrenergic receptor trafficking | Q28118801 | ||
| Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3 | Q28138462 | ||
| Association of the D2 dopamine receptor third cytoplasmic loop with spinophilin, a protein phosphatase-1-interacting protein | Q28138646 | ||
| beta 1-adrenergic receptor association with PSD-95. Inhibition of receptor internalization and facilitation of beta 1-adrenergic receptor interaction with N-methyl-D-aspartate receptors | Q28139083 | ||
| Assembly of an A kinase-anchoring protein-beta(2)-adrenergic receptor complex facilitates receptor phosphorylation and signaling | Q28141060 | ||
| Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1 | Q28142235 | ||
| A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor | Q28145098 | ||
| International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology | Q28189543 | ||
| GIPC interacts with the beta1-adrenergic receptor and regulates beta1-adrenergic receptor-mediated ERK activation | Q28201893 | ||
| Identification of G protein-coupled receptor genes from the human genome sequence | Q28202262 | ||
| Na(+)/H(+ ) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling | Q28205878 | ||
| PDZ domains and the organization of supramolecular complexes | Q28209906 | ||
| The scaffold protein gravin (cAMP-dependent protein kinase-anchoring protein 250) binds the beta 2-adrenergic receptor via the receptor cytoplasmic Arg-329 to Leu-413 domain and provides a mobile scaffold during desensitization | Q28213312 | ||
| The zeta isoform of 14-3-3 proteins interacts with the third intracellular loop of different alpha2-adrenergic receptor subtypes | Q33860370 | ||
| Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery | Q33890786 | ||
| Beyond desensitization: physiological relevance of arrestin-dependent signaling. | Q33890802 | ||
| Agonist-regulated Interaction between alpha2-adrenergic receptors and spinophilin | Q33931039 | ||
| Enhanced hypotensive, bradycardic, and hypnotic responses to alpha2-adrenergic agonists in spinophilin-null mice are accompanied by increased G protein coupling to the alpha2A-adrenergic receptor | Q34051639 | ||
| Na/H exchanger regulatory factors control parathyroid hormone receptor signaling by facilitating differential activation of G(alpha) protein subunits. | Q34094401 | ||
| The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation | Q34103312 | ||
| Allosteric binding sites on cell-surface receptors: novel targets for drug discovery | Q34139176 | ||
| Formation of a ternary complex among NHERF1, beta-arrestin, and parathyroid hormone receptor. | Q34144790 | ||
| The systematic annotation of the three main GPCR families in Reactome | Q34156723 | ||
| Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs. | Q34236107 | ||
| Heterotrimeric G proteins: organizers of transmembrane signals | Q34317073 | ||
| Role of beta-arrestin 1 in the metastatic progression of colorectal cancer | Q34335080 | ||
| M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1. | Q34397201 | ||
| NHERF1/EBP50 is a new marker in colorectal cancer | Q34411711 | ||
| G protein-coupled receptor allosterism and complexing | Q34523552 | ||
| Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. | Q34544553 | ||
| G protein-coupled receptors in major psychiatric disorders | Q34578414 | ||
| G Protein and β-arrestin signaling bias at the ghrelin receptor | Q34580340 | ||
| G-protein-coupled receptors and cancer. | Q34606002 | ||
| Regulation of G protein-coupled receptor signaling by scaffold proteins | Q34973942 | ||
| An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs | Q34985885 | ||
| Subcellular sorting of the G-protein coupled mouse somatostatin receptor 5 by a network of PDZ-domain containing proteins | Q35093658 | ||
| Activating mutations of TSH receptor | Q35111889 | ||
| G protein-coupled receptor (GPCR) signaling via heterotrimeric G proteins from endosomes | Q35172569 | ||
| The golgi-associated PDZ domain protein PIST/GOPC stabilizes the β1-adrenergic receptor in intracellular compartments after internalization | Q35172907 | ||
| G-proteins as transducers in transmembrane signalling | Q35178804 | ||
| Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling | Q35201347 | ||
| 'Biasing' the parathyroid hormone receptor: a novel anabolic approach to increasing bone mass? | Q35210020 | ||
| Endosomal generation of cAMP in GPCR signaling | Q35563982 | ||
| Parathyroid hormone: a double-edged sword for bone metabolism | Q35703582 | ||
| beta-arrestins: traffic cops of cell signaling | Q35804809 | ||
| Regulation of alpha2AR trafficking and signaling by interacting proteins | Q35828056 | ||
| GPCR interacting proteins (GIP). | Q35909078 | ||
| Mutant G-protein-coupled receptors as a cause of human diseases | Q35958795 | ||
| Biological Significance of GPCR Heteromerization in the Neuro-Endocrine System | Q35971498 | ||
| PDZ domain-containing 1 (PDZK1) protein regulates phospholipase C-β3 (PLC-β3)-specific activation of somatostatin by forming a ternary complex with PLC-β3 and somatostatin receptors | Q36033180 | ||
| Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors | Q36160942 | ||
| Spinophilin as a novel regulator of M 3 muscarinic receptor‐mediated insulin release in vitro and in vivo | Q36252363 | ||
| Design and functional characterization of a novel, arrestin-biased designer G protein-coupled receptor | Q36294407 | ||
| When 7 transmembrane receptors are not G protein-coupled receptors | Q36308861 | ||
| The PDZ scaffold NHERF-2 interacts with mGluR5 and regulates receptor activity. | Q36349480 | ||
| Heterotrimeric G-proteins: a short history | Q36364445 | ||
| The HPA and immune axes in stress: the involvement of the serotonergic system | Q36387415 | ||
| Noncanonical GPCR signaling arising from a PTH receptor-arrestin-Gβγ complex | Q36567861 | ||
| Regulation of parathyroid hormone type 1 receptor dynamics, traffic, and signaling by the Na+/H+ exchanger regulatory factor-1 in rat osteosarcoma ROS 17/2.8 cells | Q36629251 | ||
| Mechanisms of disease: Mutations of G proteins and G-protein-coupled receptors in endocrine diseases. | Q36672702 | ||
| Chronic activation of a designer Gq-coupled receptor improves β cell function | Q36733486 | ||
| Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors | Q36773326 | ||
| Therapeutic potential of β-arrestin- and G protein-biased agonists. | Q36773331 | ||
| Minireview: Novel Aspects of M3 Muscarinic Receptor Signaling in Pancreatic β-Cells | Q37050369 | ||
| Regulation of GPCRs by endocytic membrane trafficking and its potential implications | Q37053838 | ||
| Regulation of GTP-binding protein alpha q (Galpha q) signaling by the ezrin-radixin-moesin-binding phosphoprotein-50 (EBP50) | Q28218864 | ||
| The molecular acrobatics of arrestin activation | Q28257918 | ||
| Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors | Q28266829 | ||
| Cloning and characterization of MUPP1, a novel PDZ domain protein | Q28267302 | ||
| G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization | Q28276743 | ||
| Interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL) inhibits beta1-adrenergic receptor surface expression | Q28281404 | ||
| Dynamic complexes of beta2-adrenergic receptors with protein kinases and phosphatases and the role of gravin | Q28293178 | ||
| Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor | Q28301248 | ||
| Multiple actions of spinophilin regulate mu opioid receptor function | Q28512764 | ||
| beta -Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport | Q28512887 | ||
| Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor | Q28565959 | ||
| Role of Angiotensin II in Activation of the JAK/STAT Pathway Induced by Acute Pressure Overload in the Rat Heart | Q28567512 | ||
| Interactions of GIPC with Dopamine D2, D3but not D4Receptors Define a Novel Mode of Regulation of G Protein-coupled Receptors | Q28573869 | ||
| Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins | Q28578546 | ||
| Spinophilin blocks arrestin actions in vitro and in vivo at G protein-coupled receptors | Q28584983 | ||
| The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints | Q29547321 | ||
| Mechanisms linking obesity to insulin resistance and type 2 diabetes | Q29614887 | ||
| The structure and function of G-protein-coupled receptors | Q29616792 | ||
| Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor | Q29618735 | ||
| SAP97 Controls the Trafficking and Resensitization of the Beta-1-Adrenergic Receptor through Its PDZ2 and I3 Domains | Q30009852 | ||
| Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins | Q30010478 | ||
| Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling | Q30014843 | ||
| Spinophilin: from partners to functions | Q30159786 | ||
| The surprising dynamics of scaffolding proteins. | Q30409921 | ||
| Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice. | Q30476292 | ||
| CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling | Q30494303 | ||
| Conformational biosensors reveal GPCR signalling from endosomes. | Q30557505 | ||
| The angiotensin II-dependent nuclear translocation of Stat1 is mediated by the Jak2 protein motif 231YRFRR. | Q31816068 | ||
| Novel insights into G protein and G protein-coupled receptor signaling in cancer | Q33612895 | ||
| Heptahelical receptor signaling: beyond the G protein paradigm. | Q33648620 | ||
| AKAPs: from structure to function | Q33650483 | ||
| A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. | Q33779634 | ||
| Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome. | Q33794119 | ||
| P2Y1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2 | Q33841106 | ||
| RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo | Q33842962 | ||
| Inhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes | Q33844872 | ||
| The role of M(3)-muscarinic receptor signaling in insulin secretion | Q38577501 | ||
| G protein-coupled receptor 30 (GPR30) forms a plasma membrane complex with membrane-associated guanylate kinases (MAGUKs) and protein kinase A-anchoring protein 5 (AKAP5) that constitutively inhibits cAMP production | Q38981514 | ||
| Interaction of PICK1 with C-Terminus of Growth Hormone–Releasing Hormone Receptor (GHRHR) Modulates Trafficking and Signal Transduction of Human GHRHR | Q39130952 | ||
| β-arrestin2 mediates β-2 adrenergic receptor signaling inducing prostate cancer cell progression | Q39491952 | ||
| Arrestin domain-containing protein 3 recruits the NEDD4 E3 ligase to mediate ubiquitination of the beta2-adrenergic receptor. | Q39691240 | ||
| Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells. | Q39824464 | ||
| NHERF1 regulates parathyroid hormone receptor desensitization: interference with beta-arrestin binding | Q39888299 | ||
| Assembly of an SAP97-AKAP79-cAMP-dependent protein kinase scaffold at the type 1 PSD-95/DLG/ZO1 motif of the human beta(1)-adrenergic receptor generates a receptosome involved in receptor recycling and networking | Q40196135 | ||
| Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma | Q40213160 | ||
| Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy | Q40298849 | ||
| Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. | Q40313388 | ||
| Interactions with PDZ domain proteins PIST/GOPC and PDZK1 regulate intracellular sorting of the somatostatin receptor subtype 5. | Q40398562 | ||
| Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors | Q40442171 | ||
| Alpha 2-adrenergic agonist enrichment of spinophilin at the cell surface involves beta gamma subunits of Gi proteins and is preferentially induced by the alpha 2A-subtype. | Q40459777 | ||
| Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2. | Q40517882 | ||
| Spinophilin stabilizes cell surface expression of alpha 2B-adrenergic receptors | Q40648991 | ||
| A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction | Q40654414 | ||
| Regulated interactions of the alpha 2A adrenergic receptor with spinophilin, 14-3-3zeta, and arrestin 3. | Q40698015 | ||
| Role of SAP97 protein in the regulation of corticotropin-releasing factor receptor 1 endocytosis and extracellular signal-regulated kinase 1/2 signaling | Q41018207 | ||
| Desensitization of G protein-coupled receptors | Q41028988 | ||
| Heterotrimeric G proteins. | Q41099712 | ||
| Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization | Q41238228 | ||
| β1-Adrenergic Receptor Recycles Via a Membranous Organelle, Recycling Endosome, by Binding with Sorting Nexin27 | Q41510163 | ||
| Phosphorylation-dependent C-terminal binding of 14-3-3 proteins promotes cell surface expression of HIV co-receptor GPR15. | Q41955759 | ||
| Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer. | Q41985832 | ||
| Novel role for proteinase-activated receptor 2 (PAR2) in membrane trafficking of proteinase-activated receptor 4 (PAR4). | Q42061332 | ||
| Agonist-induced phosphorylation of the serotonin 5-HT2C receptor regulates its interaction with multiple PDZ protein 1. | Q42439406 | ||
| Visual arrestin interaction with rhodopsin. Sequential multisite binding ensures strict selectivity toward light-activated phosphorylated rhodopsin. | Q42623057 | ||
| Subtype-specific role of phospholipase C-beta in bradykinin and LPA signaling through differential binding of different PDZ scaffold proteins | Q43130627 | ||
| Stimulated D(1) dopamine receptors couple to multiple Galpha proteins in different brain regions | Q43735189 | ||
| AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs. | Q43845849 | ||
| Inhibition of the dopamine D1 receptor signaling by PSD-95. | Q37112269 | ||
| Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease | Q37120554 | ||
| GPCR signaling along the endocytic pathway | Q37141950 | ||
| Management of osteoporosis among the elderly with other chronic medical conditions | Q37156112 | ||
| Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin. | Q37201202 | ||
| Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer | Q37224229 | ||
| The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex | Q37273521 | ||
| Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth. | Q37318691 | ||
| The prostaglandin receptor EP2 activates multiple signaling pathways and beta-arrestin1 complex formation during mouse skin papilloma development | Q37329206 | ||
| Role of AKAP79/150 protein in β1-adrenergic receptor trafficking and signaling in mammalian cells | Q37333740 | ||
| Functionally biased signalling properties of 7TM receptors - opportunities for drug development for the ghrelin receptor | Q37337832 | ||
| A chemical-genetic approach to study G protein regulation of beta cell function in vivo. | Q37399580 | ||
| Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes | Q37443837 | ||
| Sorting of β1-adrenergic receptors is mediated by pathways that are either dependent on or independent of type I PDZ, protein kinase A (PKA), and SAP97. | Q37511764 | ||
| Spatially restricted G protein-coupled receptor activity via divergent endocytic compartments. | Q37583445 | ||
| GIPC recruits GAIP (RGS19) to attenuate dopamine D2 receptor signaling. | Q37594994 | ||
| Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery. | Q37610141 | ||
| GPCR interacting proteins (GIPs) in the nervous system: Roles in physiology and pathologies | Q37670210 | ||
| Regulation of GPCR signal networks via membrane trafficking. | Q37775131 | ||
| Beta-arrestins as regulators of signal termination and transduction: How do they determine what to scaffold? | Q37800215 | ||
| G protein-coupled receptors: mutations and endocrine diseases | Q37837505 | ||
| Refining efficacy: allosterism and bias in G protein-coupled receptor signaling. | Q37922659 | ||
| GPCR-interacting proteins, major players of GPCR function | Q37930224 | ||
| PDZ domains: the building blocks regulating tumorigenesis | Q37939947 | ||
| From parathyroid hormone to cytosolic Ca2+ signals. | Q37977175 | ||
| Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors | Q38014954 | ||
| Signalling bias in new drug discovery: detection, quantification and therapeutic impact. | Q38081692 | ||
| Arrestins: role in the desensitization, sequestration, and vesicular trafficking of G protein-coupled receptors | Q38114212 | ||
| Emerging paradigms in GPCR allostery: implications for drug discovery | Q38125563 | ||
| CRF system and mood disorders | Q38141409 | ||
| Biasing GPCR signaling from inside. | Q38182817 | ||
| Extensive shape shifting underlies functional versatility of arrestins | Q38200331 | ||
| Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective. | Q38209355 | ||
| Advances in G protein-coupled receptor allostery: from function to structure | Q38233848 | ||
| Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79. | Q38302685 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | G protein-coupled receptor | Q38173 |
| P304 | page(s) | 814-830 | |
| P577 | publication date | 2015-05-05 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Molecular Endocrinology | Q3319475 |
| P1476 | title | Minireview: Role of intracellular scaffolding proteins in the regulation of endocrine G protein-coupled receptor signaling | |
| P478 | volume | 29 |
| Q89696241 | CRISPR-Mediated Protein Tagging with Nanoluciferase to Investigate Native Chemokine Receptor Function and Conformational Changes |
| Q90438743 | Diversity of structure and function of GABAB receptors: a complexity of GABAB-mediated signaling |
| Q44778310 | Effective Attenuation of Adenosine A1R Signaling by Neurabin Requires Oligomerization of Neurabin |
| Q35999789 | Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism. |
| Q38962494 | G Protein-Coupled Receptor Endosomal Signaling and Regulation of Neuronal Excitability and Stress Responses: Signaling Options and Lessons From the PAC1 Receptor |
| Q57149243 | G Protein-Coupled Receptor Systems as Crucial Regulators of DNA Damage Response Processes |
| Q58798205 | Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity |
| Q36559089 | Molecular Characterization of Gβ-Like Protein CpcB Involved in Antifungal Drug Susceptibility and Virulence in A. fumigatus |
| Q26752261 | Oligomerization of GPCRs involved in endocrine regulation |
| Q39152860 | Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors |
| Q38830306 | Role of Scaffolding Proteins in the Regulation of TRPC-Dependent Calcium Entry |
| Q39390101 | The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT). |
Search more.